Pyripyropene derivative having ACAT2 inhibiting activity and stable to metabolizing enzymes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9187492
APP PUB NO 20130085163A1
SERIAL NO

13638332

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound effective in prevention and treatment of arteriosclerosis with a mechanism different from that of statin drugs has the following formula or a pharmaceutically acceptable salt, solvate, or hydrate thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SCHOOL JURIDICAL PERSON KITASATO INSTITUTETOKYO 108-8641

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Matsuda, Daisuke Sagamihara, JP 25 40
Nagamitsu, Tohru Sagamihara, JP 8 33
Ohshiro, Taichi Sagamihara, JP 1 1
Ohtawa, Masaki Sagamihara, JP 2 2
Omura, Satoshi Sagamihara, JP 102 462
Tomoda, Hiroshi Sagamihara, JP 44 171

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00